These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 10441148)

  • 1. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
    Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
    Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
    Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
    Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of two variants of human cystatin SA encoded by two alleles at the CST2 locus of the type 2 cystatin gene family.
    Saitoh E; Minaguchi K; Ishibashi O
    Arch Biochem Biophys; 1998 Apr; 352(2):199-206. PubMed ID: 9587407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system.
    Tseng CC; Tseng CP; Levine MJ; Bobek LA
    Arch Biochem Biophys; 2000 Aug; 380(1):133-40. PubMed ID: 10900142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
    Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
    Björk I; Brieditis I; Abrahamson M
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
    Turk B; Turk V; Turk D
    Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of plant-pathogenic fungi by the barley cystatin Hv-CPI (gene Icy) is not associated with its cysteine-proteinase inhibitory properties.
    Martínez M; López-Solanilla E; Rodríguez-Palenzuela P; Carbonero P; Díaz I
    Mol Plant Microbe Interact; 2003 Oct; 16(10):876-83. PubMed ID: 14558689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
    Jerala R; Kroon-Zitko L; Popovic T; Turk V
    Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen.
    Nägler DK; Sulea T; Ménard R
    Biochem Biophys Res Commun; 1999 Apr; 257(2):313-8. PubMed ID: 10198209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
    Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the carboxy terminal part of stefin B does not have a major effect for binding to papain.
    Jerala R; Kroon-Zitko L; Kopitar M; Popovic T; Turk V
    Biomed Biochim Acta; 1991; 50(4-6):627-9. PubMed ID: 1801733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
    Hall A; Håkansson K; Mason RW; Grubb A; Abrahamson M
    J Biol Chem; 1995 Mar; 270(10):5115-21. PubMed ID: 7890620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.